Cite
Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort.
MLA
Mynarek, Martin, et al. “Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 38, no. 18, June 2020, pp. 2028–40. EBSCOhost, https://doi.org/10.1200/JCO.19.03057.
APA
Mynarek, M., von Hoff, K., Pietsch, T., Ottensmeier, H., Warmuth-Metz, M., Bison, B., Pfister, S., Korshunov, A., Sharma, T., Jaeger, N., Ryzhova, M., Zheludkova, O., Golanov, A., Rushing, E. J., Hasselblatt, M., Koch, A., Schüller, U., von Deimling, A., Sahm, F., … Rutkowski, S. (2020). Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 38(18), 2028–2040. https://doi.org/10.1200/JCO.19.03057
Chicago
Mynarek, Martin, Katja von Hoff, Torsten Pietsch, Holger Ottensmeier, Monika Warmuth-Metz, Brigitte Bison, Stefan Pfister, et al. 2020. “Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 38 (18): 2028–40. doi:10.1200/JCO.19.03057.